NANCY CHARRON-MUSKAT: Open Payments
NPI 1316142730 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$39,698 in 202 payments from 19 companies in 2025. Trend: 2023 $30,576 · 2024 $44,290 · 2025 $39,698
Speaker / faculty: $32,925Food & beverage: $4,670Travel & lodging: $1,104Consulting: $900Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 42 | $23,318 |
| ABBVIE INC. | 47 | $12,985 |
| Lilly USA, LLC | 4 | $1,272 |
| GENZYME CORPORATION | 11 | $338 |
| Novartis Pharmaceuticals Corporation | 14 | $290 |
| UCB, Inc. | 4 | $233 |
| Arcutis Biotherapeutics, Inc. | 19 | $197 |
| Incyte Corporation | 7 | $190 |
| E.R. Squibb & Sons, L.L.C. | 11 | $158 |
| LEO Pharma Inc. | 15 | $154 |
Products named: TREMFYA, SKYRIZI, RINVOQ, EBGLYSS, DUPIXENT, Bimzelx, Zoryve, OPZELURA.
Industry payments across FL — which companies pay providers there.
